Anika Therapeutics (NASDAQ:ANIK – Get Free Report) is scheduled to be issuing its quarterly earnings data after the market closes on Thursday, August 8th. Analysts expect the company to announce earnings of $0.23 per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.
Anika Therapeutics (NASDAQ:ANIK – Get Free Report) last posted its quarterly earnings data on Wednesday, May 8th. The biotechnology company reported $0.09 EPS for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.04). The business had revenue of $40.52 million during the quarter, compared to analysts’ expectations of $39.23 million. Anika Therapeutics had a negative net margin of 45.39% and a positive return on equity of 0.48%. On average, analysts expect Anika Therapeutics to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Anika Therapeutics Stock Performance
NASDAQ:ANIK opened at $26.07 on Wednesday. Anika Therapeutics has a fifty-two week low of $16.54 and a fifty-two week high of $29.11. The company has a fifty day moving average of $26.46 and a two-hundred day moving average of $25.64. The stock has a market capitalization of $380.28 million, a PE ratio of -4.97 and a beta of 0.83.
Wall Street Analyst Weigh In
Get Our Latest Stock Report on Anika Therapeutics
About Anika Therapeutics
Anika Therapeutics, Inc, a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.
Featured Articles
- Five stocks we like better than Anika Therapeutics
- High Flyers: 3 Natural Gas Stocks for March 2022
- Uber’s Earnings Beat: Rideshare and Delivery Surge
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Hims & Hers Reports Stellar Quarter: Stock Set for a Rally
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Cloudflare Stock Flares Up on Solid EPS Beat and Raised Guidance
Receive News & Ratings for Anika Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anika Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.